Drugs / Thymosin 1 alpha
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 2 | NCT00935558 Background | Jul 2009 → May 2012 | breast cancer | Inge Marie Svane | Withdrawn | No outcome recorded Stop: Enrollment |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Thymosin 1 alpha | “1.6 mg Thymosin 1 alpha sc x 2/week” NCT00935558 ↗ |
| Known as | Thymosin 1 alpha, Zadaxin, Sigma-Tau | “Thymosin 1 alpha, Zadaxin®, Sigma-Tau” NCT00935558 ↗ |
| Route | Subcutaneous | “1.6 mg Thymosin 1 alpha sc x 2/week” NCT00935558 ↗ |